Hepatology Highlights
Almoutaz Hashim, Eric M. Yoshida
Corresponding author
Division of Gastroenterology, University of British Columbia, Vancouver Canada
Read
674
Timeswas read the article
257
Total PDF
417
Total HTML
Share statistics
array:24 [ "pii" => "S1665268119316138" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31613-8" "estado" => "S300" "fechaPublicacion" => "2010-10-01" "aid" => "71299" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2010" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2010;9:387-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 60 "formatos" => array:3 [ "EPUB" => 11 "HTML" => 18 "PDF" => 31 ] ] "itemSiguiente" => array:19 [ "pii" => "S166526811931614X" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31614-X" "estado" => "S300" "fechaPublicacion" => "2010-10-01" "aid" => "71300" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2010;9:390-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 62 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 22 "PDF" => 32 ] ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "390" "paginaFinal" => "396" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "f0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 740 "Ancho" => 1026 "Tamanyo" => 53402 ] ] "descripcion" => array:1 [ "en" => "<p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Post liver transplant survival for patients with T3 he-patocellular carcinoma compared to those with non-T3 lesions.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Timothy M. Schmitt, Sean C. Kumer, Neeral Shah, Curtis K. Argo, Patrick G. Northup" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Timothy M." "apellidos" => "Schmitt" ] 1 => array:2 [ "nombre" => "Sean C." "apellidos" => "Kumer" ] 2 => array:2 [ "nombre" => "Neeral" "apellidos" => "Shah" ] 3 => array:2 [ "nombre" => "Curtis K." "apellidos" => "Argo" ] 4 => array:2 [ "nombre" => "Patrick G." "apellidos" => "Northup" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S166526811931614X?idApp=UINPBA00004N" "url" => "/16652681/0000000900000004/v1_201906230846/S166526811931614X/v1_201906230846/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1665268119316126" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31612-6" "estado" => "S300" "fechaPublicacion" => "2010-10-01" "aid" => "71298" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Ann Hepatol. 2010;9:385-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 52 "formatos" => array:3 [ "EPUB" => 10 "HTML" => 20 "PDF" => 22 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Annals Impact Factor 1.67. Welcome to the IF club: achievement and challenges" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "385" "paginaFinal" => "386" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Claudio Tiribelli, Eric M. Yoshida, Misael Uribe" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Claudio" "apellidos" => "Tiribelli" ] 1 => array:2 [ "nombre" => "Eric M." "apellidos" => "Yoshida" ] 2 => array:2 [ "nombre" => "Misael" "apellidos" => "Uribe" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119316126?idApp=UINPBA00004N" "url" => "/16652681/0000000900000004/v1_201906230846/S1665268119316126/v1_201906230846/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Hepatology Highlights" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "387" "paginaFinal" => "389" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Almoutaz Hashim, Eric M. Yoshida" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Almoutaz" "apellidos" => "Hashim" ] 1 => array:4 [ "nombre" => "Eric M." "apellidos" => "Yoshida" "email" => array:1 [ 0 => "eric.yoshida@vch.ca" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor1" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Division of Gastroenterology, University of British Columbia, Vancouver Canada" "identificador" => "aff1" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "*" "correspondencia" => "Correspondence and reprint request:" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis</span><p id="p0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Yamamoto-Furusho K, <span class="elsevierStyleItalic">et al.</span></span> Hepatobiliary diseases are well recognized in inflammatory bowel disease (IBD) frequently presenting as abnormal serum liver biochemistry.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The associated liver and biliary tract disease range from minor conditions, such as liver fatty changes, to severe diseases including primary sclerosing cholangitis and autoimmune hepatitis. The reported prevalence of IBD associated to hepatobiliary diseases has varied from 3% to greater than 50%.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="p0010" class="elsevierStylePara elsevierViewall">In this issue, Yamamoto-Furusho, <span class="elsevierStyleItalic">et al.,</span> report their prospective single center study to investigate the prevalence of abnormal serum liver biochemical tests and risk factors associated with their development in Mexican patients with ulcerative colitis (UC). This is noteworthy as UC in Latin America may be genetically and phenotypically different to other populations. From January 1, 2007 to December 31, 2008 at the Instituto Nacional de Ciencias Médicas y Nutrición Hospital in Mexico, 200 patients (94 females, 106 males) with UC, who did not consume a significant amount of alcohol, were evaluated. A high prevalence of abnormal serum liver biochemical tests was found in 40%. The pattern of abnormal serum tests was hepacellular (70%), cho-lestatic (20%) and mixed (10%). The most common occurrence of the abnormal serum tests was a transient elevation in 63%, presumably not reflective of significant hepatobiliary disease. The hepatobiliary diseases resulting in the abnormal tests were: fatty liver disease (11.2%), primary sclerosing cholangitis (6.3%), drug-toxicity (6%) and other conditions (13.5%) including chronic hepatitis C, total parenteral nutrition associated disease, granulomatous and ischemic hepatitis. Factors found to be associated with the abnormal serum liver biochemistry included: intermittent activity of UC, surgical procedure including colectomy, active UC, abdominal sepsis and the presence of a positive ANA serology.</p><p id="p0015" class="elsevierStylePara elsevierViewall">The present study confirms the relationship between UC and abnormal liver biochemistry. Non-alcoholic fatty liver disease turned out to be less common in this population than previously reported. Of interest, the majority of the patients in this study had an unknown cause for the abnormal serum liver biochemistry. Although this is a one center study, the results obtained may be limited to this center. However, this study does contribute to the understanding of UC patients in Mexico in relationship to abnormal liver biochemical abnormalities that appeared very commonly, and associated to hepatobiliary diseases.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens</span><p id="p0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Gutierrez-Grobe Y, <span class="elsevierStyleItalic">et al.</span></span> Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are becoming increasingly prevalent world-wide. In North America, the prevalence overall is estimated to be 30% and amongst the obese population (i.e. BMI >30), it can be as high as 70%. Risk factors for fatty liver disease throughout the world include the adoption of a high-calorie diet that may be attributable to the wide-spread influence of an American-style diet. Epidemiologic studies suggest that Hispanics and diabetic patients are at greatest risk for both NAFLD and NASH.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Insulin resistance has been implicated in the pathogenesis of both nonalcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS).<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="p0025" class="elsevierStylePara elsevierViewall">The aim of the study of Gutierrez-Grobe, <span class="elsevierStyleItalic">et al.</span> was to investigate the prevalence of NAFLD in pre-menopausal, postmenopausal and polycystic ovary syndrome (PCOS) women in a cross-sectional study performed at the University Hospital in Mexico City between February 2009 and December 2009. Metabolic and biochemical variables were measured. Serum estradiol and cortisol concentrations were determined and compared between the groups. The study included 197 female subjects, of whom 93(47.2%) had NAFLD and 104 (52.8%) did not have NAFLD. There were 90 premenopausal patients (46.2%), 57 post-menopausal patients (29.4%) and 50 PCOS patients (25.4%). The prevalence of NAFLD in premenopausal, postmenopausal and PCOS patients was 32.2%, 57.9%, and 62%, respectively. The authors concluded that NAFLD is more prevalent in postmenopausal and women with PCOS than those premenopausal ones and that estrogen may have a protective effect of against NAFLD in women.</p><p id="p0030" class="elsevierStylePara elsevierViewall">This study highlights the prevalence of NAFLD among postmenopausal women and generates a hypothesis that there may be a protective effect of estrogen. One limitation to the study is that the diagnosis of NAFLD was made based on ultrasound and liver biopsy was not performed, therefore, the prevalence of NAFLD may have been underestimated. It would be of interest to have the hypothesis that estrogen protects against NAFLD formally studied in the future.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states.</span><p id="p0035" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Méndez-Sánchez N., <span class="elsevierStyleItalic">et al.</span></span> Liver disease is a major health issue all over the world. According to the Office for National Statistics in the United Kingdom, liver disease is now the fifth most common cause of death. However, unlike other major causes of mortality, liver disease rates are increasing.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Liver diseases may be secondary to several etiologies including alcoholic liver disease, viral hepatitis, non alcoholic fatty liver disease (NAFLD) and liver cancer. In Mexico liver disease is the second leading cause of death in people aged between 35 and 55.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Alcohol-related liver diseases remain the most important causes of chronic liver disease in Mexico.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> Several studies have been performed to analyze the impact of liver diseases on the Mexican population, but not one has compared the geographic distribution of disease within the different states of Mexico.</p><p id="p0040" class="elsevierStylePara elsevierViewall">The aim of this study was to analyze trends in mortality associated with liver diseases in Mexico from 2000 to 2007 at both the national and state levels. Open-access databases were used to obtain data on deaths registered by the Ministry of Health of Mexico. Mortality due to viral hepatitis, liver tumors, and cirrhosis increased over the study period. Alcohol-related mortality decreased but was still the main cause of liver-related deaths. Hepatitis infection occurred predominantly in the northern states and liver tumors occurred predominantly in the central region. Alcohol-related deaths were elevated along the Pacific shoreline and deaths associated with cirrhosis occurred mainly in the central and southern states. This study concluded that liver-related mortality has increased significantly at the provincial and national levels and it is estimated that it will continue to increase.</p><p id="p0045" class="elsevierStylePara elsevierViewall">The present study confirms the increase in mortality associated with chronic liver disease in Mexico, and at the same time provides an interesting look at prevalence of the different causes of liver disease across geographic regions of Mexico. Liver disease clearly remains a significant problem in that country. Although a decrease in alcohol related mortality was reported, alcohol remains the primary cause of liver disease in Mexico. This is a disturbing finding as alcoholic liver disease is completely preventable and therefore mortality from this form of liver disease is tragically unnecessary. This article highlights the need for effective public health programs in Mexico with regards to alcohol and the need for improved awareness in Mexican society about the morbidity and mortality associated with alcohol.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states." ] 3 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bs0005" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:4 [ 0 => "Lepistö A." 1 => "Kivistö S." 2 => "Kivisaari L." 3 => "Arola J." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00384-009-0773-4" "Revista" => array:7 [ "tituloSerie" => "Int J Colorectal Dis" "fecha" => "2009" "volumen" => "24" "numero" => "10" "paginaInicial" => "1169" "paginaFinal" => "1174" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19636573" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Broomé U." 1 => "Löfberg R." 2 => "Veress B." 3 => "Eriksson L.S." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hepatol" "fecha" => "1997" "volumen" => "25" "numero" => "1" "paginaInicial" => "254" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:4 [ 0 => "Broomé U." 1 => "Glaumann H." 2 => "Hellers G." 3 => "Nilsson B." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gut.35.1.84" "Revista" => array:6 [ "tituloSerie" => "Gut" "fecha" => "1994" "volumen" => "35" "paginaInicial" => "84" "paginaFinal" => "89" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8307457" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Jeanne C." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.mcg.0000168638.84840.ff" "Revista" => array:6 [ "tituloSerie" => "J Clin Gastroenterol" "fecha" => "2006" "volumen" => "40" "paginaInicial" => "S5" "paginaFinal" => "S10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16540768" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:4 [ 0 => "Williams C.D." 1 => "Stengel J." 2 => "Asike M.I." 3 => "Torres D.M." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Gastroenterol" "fecha" => "2010" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:4 [ 0 => "Gambarin-Gelwan M." 1 => "Kinkhabwala S.V." 2 => "Schiano T.C." 3 => "Bodian C." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2006.10.010" "Revista" => array:6 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2007" "volumen" => "5" "paginaInicial" => "496" "paginaFinal" => "501" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17287148" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "UK national statistics. Available at: <a href="http://www.statistics.gov.uk/">http://www.statistics.gov.uk/</a>" ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "Méndez-Sánchez N." 1 => "Villa A.R." 2 => "Chávez-Tapia N.C." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2005" "volumen" => "4" "numero" => "1" "paginaInicial" => "52" "paginaFinal" => "55" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15798662" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Secretaría de Salud M. Base de datos de información sobre mortalidad. Available at: <a href="http://www.salud.gob.mx/apps/htdocs/estadisticas/publicaciones/Mortalidad2000.zip">http://www.salud.gob.mx/apps/htdocs/estadisticas/publicaciones/Mortalidad2000.zip.</a> Access: 3th January 2005." ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000000900000004/v1_201906230846/S1665268119316138/v1_201906230846/en/main.assets" "Apartado" => array:4 [ "identificador" => "77938" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Hepatology highlights" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000000900000004/v1_201906230846/S1665268119316138/v1_201906230846/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119316138?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 8 | 2 | 10 |
| 2024 September | 2 | 1 | 3 |
| 2024 August | 5 | 2 | 7 |
| 2024 July | 8 | 0 | 8 |
| 2024 June | 10 | 5 | 15 |
| 2024 May | 10 | 2 | 12 |
| 2024 April | 13 | 4 | 17 |
| 2024 March | 9 | 1 | 10 |
| 2024 February | 6 | 5 | 11 |
| 2024 January | 6 | 3 | 9 |
| 2023 December | 2 | 3 | 5 |
| 2023 November | 4 | 2 | 6 |
| 2023 October | 8 | 5 | 13 |
| 2023 September | 2 | 1 | 3 |
| 2023 August | 3 | 4 | 7 |
| 2023 July | 4 | 6 | 10 |
| 2023 June | 17 | 1 | 18 |
| 2023 May | 37 | 0 | 37 |
| 2023 April | 1 | 0 | 1 |
| 2023 March | 4 | 4 | 8 |
| 2023 February | 2 | 0 | 2 |
| 2023 January | 3 | 2 | 5 |
| 2022 December | 8 | 3 | 11 |
| 2022 November | 4 | 4 | 8 |
| 2022 October | 6 | 4 | 10 |
| 2022 September | 4 | 6 | 10 |
| 2022 August | 6 | 7 | 13 |
| 2022 July | 7 | 6 | 13 |
| 2022 June | 4 | 5 | 9 |
| 2022 May | 9 | 5 | 14 |
| 2022 April | 6 | 7 | 13 |
| 2022 March | 7 | 7 | 14 |
| 2022 February | 5 | 3 | 8 |
| 2022 January | 15 | 7 | 22 |
| 2021 December | 6 | 8 | 14 |
| 2021 November | 6 | 4 | 10 |
| 2021 October | 25 | 7 | 32 |
| 2021 September | 26 | 9 | 35 |
| 2021 August | 7 | 2 | 9 |
| 2021 July | 5 | 6 | 11 |
| 2021 June | 8 | 8 | 16 |
| 2021 May | 5 | 7 | 12 |
| 2021 April | 13 | 12 | 25 |
| 2021 March | 10 | 2 | 12 |
| 2021 February | 6 | 6 | 12 |
| 2021 January | 4 | 8 | 12 |
| 2020 December | 4 | 4 | 8 |
| 2020 November | 4 | 8 | 12 |
| 2020 October | 3 | 4 | 7 |
| 2020 September | 5 | 4 | 9 |
| 2020 August | 6 | 1 | 7 |
| 2020 July | 2 | 1 | 3 |
| 2020 June | 3 | 2 | 5 |
| 2020 May | 2 | 2 | 4 |
| 2020 April | 1 | 1 | 2 |
| 2020 March | 3 | 3 | 6 |
| 2020 February | 3 | 1 | 4 |
| 2020 January | 3 | 3 | 6 |
| 2019 December | 4 | 7 | 11 |
| 2019 November | 5 | 1 | 6 |
| 2019 August | 1 | 1 | 2 |
| 2019 July | 1 | 13 | 14 |
| 2019 June | 1 | 5 | 6 |
Show all
